TY - JOUR
T1 - Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction
AU - Poletto, Edoardo
AU - Olthof, Pim B.
AU - Ruzzenente, Andrea
AU - Adam, Jean-Philippe
AU - Alwayn, Ian P. J.
AU - Boleslawski, Emmanuel
AU - de Boer, Marieke T.
AU - Chebaro, Alexandre
AU - Chiche, Laurence
AU - Dopazo, Cristina
AU - Dubbeld, Jeroen
AU - Erdmann, Joris I.
AU - Hakeem, Abdul
AU - Coenraad, Minneke J.
AU - Kuipers, Hendrien
AU - Mabrut, Jean-Yves
AU - Maulat, Charlotte
AU - Maithel, Shishir K.
AU - de Meijer, Vincent E.
AU - Mohkam, Kayvan
AU - Murad, Sarwa Darwish
AU - Muscari, Fabrice
AU - Rolinger, Jens
AU - Polak, Wojciech G.
AU - Rayar, Michel
AU - Ratti, Francesca
AU - Robin, Fabien
AU - Schnitzbauer, Andreas A.
AU - Sparrelid, Ernesto
AU - van Vilsteren, Frederike G. I.
AU - Porte, Robert J.
AU - Hoogwater, Frederik J. H.
AU - Groot Koerkamp, Bas
AU - the Perihilar Cholangiocarcinoma Collaboration Group
AU - Aldrighetti, L.
AU - Bechstein, W. O.
AU - de Boer, M. A.
AU - Büttner, S.
AU - Capobianco, I.
AU - Charco, R.
AU - Franken, L. C.
AU - Gilg, S.
AU - Gomez-Gavara, C.
AU - Guglielmi, A.
AU - van Gulik, T. M.
AU - Heil, J.
AU - Jansson, H.
AU - Kazemier, G.
AU - Lodge, P.
AU - Marino, R.
AU - Nadalin, S.
AU - Nguyen, T. A.
AU - Prasad, R.
N1 - Publisher Copyright:
© 2026 The Author(s). Liver International published by John Wiley & Sons Ltd.
PY - 2026/7/1
Y1 - 2026/7/1
N2 - Background and Aims: Liver resection (LR) and orthotopic liver transplantation (OLT) are therapeutic options for locally advanced perihilar cholangiocarcinoma (pCCA) requiring hepatic artery reconstruction (HAR). This study aimed to compare short- and long-term outcomes of LR and OLT. Outcomes were major vascular complications, 90-day mortality, overall survival (OS) and recurrence-free survival (RFS). Methods: A cohort of patients undergoing LR with HAR from 10 Western centres was compared with an OLT cohort comprising patients who received or did not receive neoadjuvant chemoradiotherapy (NACR). Results: 109 patients, 60 LR and 49 OLT (22 OLT no-NACR and 27 OLT NACR) were included. LR patients were older and had fewer Bismuth type 4 tumours (38.3% vs. 69.4%, p = 0.009). Positive margins (49.2% vs. 6.5%, p < 0.001) and lymph nodes (54.2% vs. 32.4%, p = 0.058) were found more frequently in LR patients. No differences were found between LR and OLT in major (40% vs. 46.9%, p = 0.56) and vascular complications (23.3% vs. 28.6%, p = 0.66); NACR was an independent prognostic factor for vascular complications (OR 2.63, 95% CI 1.03–6.70, p = 0.043). 90-day mortality (15% for LR vs. 10.2% for OLT, p = 0.57) and 5-year OS (HR 0.68, 95% CI 0.40–1.17, p = 0.17) were similar. Median OS after LR versus OLT was higher but not significant (24 vs. 40 months, p = 0.13). OLT had better 5-year RFS (HR 0.52, 95% CI 0.29–0.96, p = 0.035) than LR. R1 resection (HR 2.07, 95% CI 1.03–4.18, p = 0.041) and perineural invasion (HR 3.64, 95% CI 1.09–12.16, p = 0.035) were independent prognostic factors for RFS. Conclusions: LR and OLT for locally advanced pCCA had similar rates of major complications and post-operative mortality, but NACR was associated with increased vascular complications. Survival was difficult to compare in the groups due to their heterogeneity, but OLT, especially with NACR, seems to give better results than LR.
AB - Background and Aims: Liver resection (LR) and orthotopic liver transplantation (OLT) are therapeutic options for locally advanced perihilar cholangiocarcinoma (pCCA) requiring hepatic artery reconstruction (HAR). This study aimed to compare short- and long-term outcomes of LR and OLT. Outcomes were major vascular complications, 90-day mortality, overall survival (OS) and recurrence-free survival (RFS). Methods: A cohort of patients undergoing LR with HAR from 10 Western centres was compared with an OLT cohort comprising patients who received or did not receive neoadjuvant chemoradiotherapy (NACR). Results: 109 patients, 60 LR and 49 OLT (22 OLT no-NACR and 27 OLT NACR) were included. LR patients were older and had fewer Bismuth type 4 tumours (38.3% vs. 69.4%, p = 0.009). Positive margins (49.2% vs. 6.5%, p < 0.001) and lymph nodes (54.2% vs. 32.4%, p = 0.058) were found more frequently in LR patients. No differences were found between LR and OLT in major (40% vs. 46.9%, p = 0.56) and vascular complications (23.3% vs. 28.6%, p = 0.66); NACR was an independent prognostic factor for vascular complications (OR 2.63, 95% CI 1.03–6.70, p = 0.043). 90-day mortality (15% for LR vs. 10.2% for OLT, p = 0.57) and 5-year OS (HR 0.68, 95% CI 0.40–1.17, p = 0.17) were similar. Median OS after LR versus OLT was higher but not significant (24 vs. 40 months, p = 0.13). OLT had better 5-year RFS (HR 0.52, 95% CI 0.29–0.96, p = 0.035) than LR. R1 resection (HR 2.07, 95% CI 1.03–4.18, p = 0.041) and perineural invasion (HR 3.64, 95% CI 1.09–12.16, p = 0.035) were independent prognostic factors for RFS. Conclusions: LR and OLT for locally advanced pCCA had similar rates of major complications and post-operative mortality, but NACR was associated with increased vascular complications. Survival was difficult to compare in the groups due to their heterogeneity, but OLT, especially with NACR, seems to give better results than LR.
KW - biliary tract tumours
KW - cholangiocarcinoma
KW - liver resection
KW - transplantation surgery
KW - vascular reconstruction
KW - vascular resection
UR - https://www.scopus.com/pages/publications/105042587020
U2 - 10.1111/liv.70729
DO - 10.1111/liv.70729
M3 - Article
C2 - 42324714
SN - 1478-3223
VL - 46
JO - Liver international
JF - Liver international
IS - 7
M1 - e70729
ER -